ClinicalTrials.gg
RecruitingNCT06384430Updated Sep 25, 2024

Subacromial Impingement Syndrome Functional Tests Correlation With Ultrasound Parameters

An observational study in Subacromial Impingement Syndrome, Shoulder Tendinitis and Shoulder Bursitis, sponsored by Muğla Sıtkı Koçman University. Recruiting at 1 site in Turkey. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2024-09-25.

Sponsored by Muğla Sıtkı Koçman University · Observational

From the registry’s dates

  • Primary completion was expected by Sep 2024, 2 years 1 month ago, but the record still lists the study as recruiting.
  • Started Apr 2024; still recruiting 2 years 7 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
70
Ages
18 Years to 70 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-13

Among 69 studies in Shoulder Impingement Syndrome with a site in Turkey — 12 open to participants now, 14 under way, none of them phase 3. Shoulder Impingement Syndrome · Turkey.

Planned enrollment
8th of 14
70 · median 77
Started
2024
with 6 others
Observational
14 of 69
4 open now
Primary completion
2024-09
later than 1 of 13 live
Registered
44th of 69
by date

Among the 69 studies in Shoulder Impingement Syndrome with a site in Turkey, this one is the 8th largest by planned enrollment of the 14 observational ones that give a count, is one of 7 that started in 2024, is one of 14 observational ones, reaches primary completion later than 1 of the 13 other live ones, and was the 44th registered.

Shoulder Impingement Syndrome

320 studies on the registry are indexed under Shoulder Impingement Syndrome; 62 are open to participants now.

Browse Shoulder Impingement Syndrome studies →

Open to participants now

12 of the 69 studies in Shoulder Impingement Syndrome with a site in Turkey are open now. Recruiting first, the newest first:

6 more — sign in →

All 12 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 32 Shoulder Impingement Syndrome studies recruiting now, 3 (9%) set no upper age limit and 25 (78%) stop at 75 or younger; 1 takes children under 18; 6 take healthy volunteers.

This study: 18 Years to 70 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Watch this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 69 studies in Shoulder Impingement Syndrome with a site in Turkey, or all of them as a file.
02

Study summary

In this study, among the patients who applied to the Physical Medicine and Rehabilitation outpatient clinic of Muğla Training and Research Hospital and were diagnosed with subacromial impingement by anamnesis and clinical tests, inclusion criteria) and exclusion criteria will be included in the study. Demographic data of the patients will then be recorded. DASH (Disabilities of the Arm, Shoulder and Hand) and Constant Murley scores will be calculated. 4 years of musculoskeletal ultrasound experience will be recorded by a radiologist using ultrasound (Siemens® V8, LA2-14A probe) in modified Crass position (positioning with the palm of the examined side on the posterior iliac wing) by measuring subacromial bursa thickness, supraspinatus tendon thickness, acromiohumeral distance, supraspinatus tendon thickness/acromiohumeral distance ratio. Demographic data of the patients will then be recorded. DASH (Disabilities of the Arm, Shoulder and Hand) and Constant Murley scores will be calculated.

Read the detailed description

Subacromial impingement syndrome is a common shoulder pain disorder. In this study, among the patients who applied to the Physical Medicine and Rehabilitation outpatient clinic of Muğla Training and Research Hospital and were diagnosed with subacromial impingement by anamnesis and clinical tests, inclusion criteria (being between 18-70 years of age, positivity for subacromial impingement syndrome in clinical evaluation (Neer's test, Hawkins Kennedy, supraspinatus palpation test)) and exclusion criteria (under 18 years of age, over 70 years of age, rheumatologic disease diagnosis, symptomatic shoulder osteoarthritis, shoulder instability; shoulder pain in active, passive cervical spine movements, previous shoulder surgery, those with adhesive capsulitis findings (>50% passive range of motion restriction in 2 planes or full-thickness rotator cuff tear detected on ultrasound), those who received physiotherapy or intra-articular injections in the last 3 months, those with type 2 diabetes or hypothyroidism) will be included in the study. Demographic data of the patients will then be recorded. DASH (Disabilities of the Arm, Shoulder and Hand) and Constant Murley scores will be calculated. 4 years of musculoskeletal ultrasound experience will be recorded by a radiologist using ultrasound (Siemens® V8, LA2-14A probe) in modified Crass position (positioning with the palm of the examined side on the posterior iliac wing) by measuring subacromial bursa thickness, supraspinatus tendon thickness, acromiohumeral distance, supraspinatus tendon thickness/acromiohumeral distance ratio. Demographic data of the patients will then be recorded. DASH (Disabilities of the Arm, Shoulder and Hand) and Constant Murley scores will be calculated.

03

Conditions studied

  • Subacromial Impingement Syndrome
  • Shoulder Tendinitis
  • Shoulder Bursitis
  • Shoulder Pain
04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Being between 18-70 years old and clinical evaluation positive for subacromial impingement syndrome.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Being between 18-70 years old
  2. Clinical evaluation positive for subacromial impingement syndrome (Neer's test, Hawkins Kennedy, supraspinatus palpation test)

Exclusion criteria

Exclusion Criteria:

  1. Under 18, over 70 years of age
  2. Those diagnosed with rheumatologic diseases
  3. Those with symptomatic shoulder osteoarthritis
  4. Those with shoulder instability
  5. Shoulder pain in active, passive cervical spine movements
  6. Previous shoulder surgery
  7. Findings of adhesive capsulitis (>50% restriction of passive range of motion in 2 planes or detection of a full-thickness rotator cuff tear on ultrasound)
  8. Physiotherapy or intra-articular injection in the last 3 months
  9. Diagnosis of type 2 diabetes or hypothyroidism
05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
70 participants (estimated)
Target follow-up
1 Day
Patient registry
Yes

Groups and cohorts

  • Patients with subacromial impingement syndrome

    Patients with subacromial impingement syndrome: Being between 18-70 years old Clinical evaluation positive for subacromial impingement syndrome (Neer's test, Hawkins Kennedy, supraspinatus palpation test)

    Diagnostic Test: Shoulder functional tests and ultrasound

Interventions

  • Diagnostic testShoulder functional tests and ultrasound

    On the day of the study, demographic data will be collected from patients with a clinical diagnosis of impingement and who agree to participate in the study, then DASH and Constant Murley scores will be calculated and subacromial bursa thickness, supraspinatus tendon thickness, acromiohumeral distance, supraspinatus tendon thickness/acromiohumeral distance ratio will be calculated on ultrasound.

06

What researchers measure

Primary outcomes

  1. subacromial bursa thickness

    subacromial bursa thickness measure

    Time frame: 1 day

  2. supraspinatus tendon thickness

    supraspinatus tendon thickness measure

    Time frame: 1 day

  3. acromiohumeral distance

    acromiohumeral distance measure

    Time frame: 1 day

07

Study locations

1 of 1 sites recruiting
  • Mugla Egitim Arastima
    Mugla, Turkey
    Recruiting
    • Nihal KARAYER OZGUL, 1 · Contact
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Apr 2024 (actual). Primary completion is estimated for Sep 2024, 5 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 22, 2024
First posted
Apr 25, 2024
StartActual
Apr 1, 2024
Primary completionEst.
Sep 30, 2024
CompletionEst.
Oct 31, 2024
Last update
Sep 25, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 25, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06384430
Responsible party
Nihal KARAYER OZGUL (Principal Investigator, Muğla Sıtkı Koçman University) — Principal investigator
First posted
Apr 25, 2024
Start date
Apr 1, 2024
Primary completion
Sep 30, 2024 (estimated)
Completion
Oct 31, 2024 (estimated)
Last update
Sep 25, 2024

Study contacts

Nihal KARAYER OZGUL, 1
Contact
nihalkarayer505@gmail.com
+905073068312

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion